new_0222_0416|AKYA|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|sga_expense|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|price_next_month|price_second_month
new_0222_0416|AKYA|1|Akoya Biosciences Inc Total Current Assets (Quarterly) (USD)|Akoya Biosciences Inc Cash and Short Term Investments (Quarterly) (USD)|Akoya Biosciences Inc Inventories (Quarterly) (USD)|Akoya Biosciences Inc Net PP&E (Quarterly) (USD)|Akoya Biosciences Inc Goodwill and Intangibles (Quarterly) (USD)|Akoya Biosciences Inc Total Liabilities (Quarterly) (USD)|Akoya Biosciences Inc Total Current Liabilities (Quarterly) (USD)|Akoya Biosciences Inc Total Long Term Liabilities (Quarterly) (USD)|Akoya Biosciences Inc Total Deposits (Quarterly) (USD)|Akoya Biosciences Inc Book Value (Quarterly) (USD)|Akoya Biosciences Inc Retained Earnings (Quarterly) (USD)|Akoya Biosciences Inc Treasury Stock (Quarterly) (USD)|Akoya Biosciences Inc EV to Revenues|Akoya Biosciences Inc EV to Earnings|Akoya Biosciences Inc EV to Free Cash Flow|Akoya Biosciences Inc EV to Assets (Quarterly)|Akoya Biosciences Inc PS Ratio|Akoya Biosciences Inc PE Ratio|Akoya Biosciences Inc Price to Book Value|Akoya Biosciences Inc PEG Ratio|Akoya Biosciences Inc Debt to Equity Ratio|Akoya Biosciences Inc Dividend Yield|Akoya Biosciences Inc Shareholder Yield (TTM)|Akoya Biosciences Inc Percent of Shares Outstanding Short|Akoya Biosciences Inc Total Receivables (Quarterly) (USD)|Akoya Biosciences Inc Total Payables (Quarterly) (USD)|Akoya Biosciences Inc Total Capital Stock (Quarterly) (USD)|Akoya Biosciences Inc Return on Invested Capital|Akoya Biosciences Inc Quality Ratio Score|Akoya Biosciences Inc Momentum Score|Akoya Biosciences Inc Beta (1Y)|Akoya Biosciences Inc Sustainable Growth Rate (TTM)|Akoya Biosciences Inc Institutional Investor Ownership Percentage|Akoya Biosciences Inc Average Diluted Shares Outstanding (Quarterly)|Akoya Biosciences Inc Total Employees (Annual)|Akoya Biosciences Inc EPS Diluted (Quarterly) (USD)|Akoya Biosciences Inc Shares Outstanding|Akoya Biosciences Inc Repurchase of Capital Stock (Quarterly) (USD)|Akoya Biosciences Inc Ordinary Shares Number (Quarterly)|Akoya Biosciences Inc Payout Ratio|Akoya Biosciences Inc Quick Ratio (Quarterly)|Akoya Biosciences Inc Normalized Diluted EPS (Quarterly) (USD)|Akoya Biosciences Inc Stock Buybacks (Quarterly) (USD)|Akoya Biosciences Inc Effective Tax Rate (TTM)|Akoya Biosciences Inc Return on Equity|Akoya Biosciences Inc Net Income (TTM) (USD)|Akoya Biosciences Inc Revenue (TTM) (USD)|Akoya Biosciences Inc Dividend Per Share (Quarterly) (USD)|Akoya Biosciences Inc Revenue (Quarterly) (USD)|Akoya Biosciences Inc Gross Profit (Quarterly) (USD)|Akoya Biosciences Inc SG&A Expense (Quarterly) (USD)|Akoya Biosciences Inc Pre-Tax Income (Quarterly) (USD)|Akoya Biosciences Inc Net Income (Quarterly) (USD)|Akoya Biosciences Inc Net Interest Income (Quarterly) (USD)|Akoya Biosciences Inc Price (USD)|Akoya Biosciences Inc Total Return Price (USD)|Akoya Biosciences Inc Enterprise Value (USD)|Akoya Biosciences Inc 30-Day Average Daily Volume|Akoya Biosciences Inc 1 Year Price Returns (Daily)||
new_0222_0416|AKYA|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric||
new_0222_0416|AKYA|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|quarterly||
new_0222_0416|AKYA|5|91|91|91|91|91|91|91|91||91|91||1.44131455399|92|1.44131455399|92|1.43925233645||1.43827160494||91|1.44131455399|92|15.3333333333|91|91|91|92|92|||92|30.6666666667|91.3333333333||91.3333333333|28.8571428571||91|91|91|91.3333333333|91.4|91|92|91|91||91.3333333333|91.3333333333|91.3333333333|91.3333333333|91.3333333333|91.3333333333|1.43925233645|1.43925233645|1.44131455399|1.44565217391|||
new_0222_0416|AKYA|6|3|3|3|3|3|3|3|3||3|3||213|1|213|1|214||162||3|213|1|18|3|3|3|1|1|||1|9|6||6|7||3|3|3|6|5|3|1|3|3||6|6|6|6|6|6|214|214|213|184|||
new_0222_0416|AKYA|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily||
new_0222_0416|AKYA|202003||||||||||||||||||||||||||||||||||28.9162||-0.0741||||||-0.0741|||||||11.021|6.696|6.349|-2.105|-2.143|-0.637|||||||
new_0222_0416|AKYA|202006||||||||||||||||||||||||||||||||||28.9162||-0.21||||||-0.1586|||||||8.56|5.27|5.105|-4.546|-4.585|-0.658|||||||
new_0222_0416|AKYA|202009||||||||||||||||||||||||||||||||||28.9162||-0.1995||||||-0.1482|||||||9.954|6.034|5.712|-4.293|-4.284|-0.683|||||||
new_0222_0416|AKYA|202012|28.696|17.006|4.263|5.528|40.976|59.089|17.162|41.927||18.571|-52.28||||||||||1.8588||||6.47|5.074|0.002|||||||28.9162|169|-0.2381|||37.1369||1.3679|-0.1291||-0.252||-16.706|42.443||12.908|7.908|6.816|-5.72|-5.694|-0.745|||||||
new_0222_0416|AKYA|202103|24.034|11.691|4.718|6.053|40.422|134.481|20.558|113.923||-61.253|-61.254||19.6394||-65.4358||15.7418||||-0.5771|||0.5722|6.59|5.776|1.254||||||5.5538|35.6893||-0.2265|37.1105||35.6893||0.8892|-0.1741||0.0088||-22.645|43.634||12.212|7.405|8.179|-8.088|-8.082|-0.751|22.44|22.44|856.9476|157533.1333||20.82|
new_0222_0416|AKYA|202106|157.409|135.464|6.562|6.02|39.906|58.521|18.161|40.36||147.821|-66.817||12.7743|-26.0348|-25.7234|2.9806|12.4022||4.8588||0.2182||-20.1892|1.679|8.158|4.898|0.002|-34.1054|6|||-67.4051|39.9875|29.9748||-0.2|37.1369||37.1369||7.9083|-0.2539|-138.553|0.1986|-67.4051|-23.623|48.145||13.071|8.134|10.066|-5.569|-5.563|-0.757|19.34|19.34|615.0196|144245.0333||17.34|15.97
new_0222_0416|AKYA|202109|145.66|120.15|6.093|6.492|39.636|58.019|17.3|40.719||137.392|-78.434||8.3459|-13.9298|-11.7891|2.2067|8.899||3.7775||0.2356||-27.9435|1.5925|9.605|4.071|0.002|-32.7968|5|||-51.0549|35.6217|37.1625||-0.31|37.1774||37.1774||7.5003|-0.31||0.158|-51.0549|-30.956|51.667||13.476|8.453|13.725|-11.628|-11.617|-0.763|13.96|13.96|431.2095|84786.1333||13.25|12.98
new_0222_0416|AKYA|202112|||||||||||||9.3263||-13.174||9.7595||4.1462|||||1.4381|||||||||36.1436||||||||||||||||||||||15.31|15.31|481.8644|278403.6667||11.36|11.48